EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autonomous Hydrogel Actuators Programmed by Endogenous Biochemical Logic for Dual‐Stage Morphing and Drug Release

Yuchen Liu, Harischandra Potthuri, Alejandro Sosnik iD, Luai R Khoury iD

Advanced Materials · 2026-02 · 38 (12)

DOI: 10.1002/adma.202516809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 21.01.2026. Verfasst von Yuchen Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, Technion Israel Institute of Technology, Haifa, Israel. Hauptthemen laut MEDLINE: Hydrogels, Drug Liberation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israeli Centers for Research Excellence, Neubauer Family Foundation, Tamara and Harry Handelsman Academic Chair.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Designing soft materials that autonomously respond to complex physiological environments remains a fundamental challenge in biomedical systems engineering. Here, we report on a 3D‐printed hybrid protein‐polymer hydrogel actuator that operates via endogenous biochemical logic , enabling fully autonomous dual‐stage shape morphing and enzyme‐triggered drug release in gastric‐mimicking environments. The actuator comprises a bilayer structure: an active layer based on bovine serum albumin‐poly (ethylene glycol) diacrylate (BSA‐PEGDA), and a passive PEGDA layer. In acidic gastric fluid, the BSA‐PEGDA layer undergoes rapid conformational swelling, followed by delayed softening from pepsin‐mediated degradation, autonomously driving reversible shape transitions without manual intervention. By embedding doxorubicin (DOX) within the BSA‐PEGDA hydrogel network, the system achieves site‐specific, enzyme‐gated drug release that is tunable using pepstatin A as a biochemical inhibitor. High‐resolution digital light processing (DLP) printing enables the fabrication of complex autonomous actuators and microneedle‐equipped grippers capable of mucosal adhesion, catch‐and‐release behavior, and controlled delivery. This work establishes a materials design strategy where biochemical cues are used as programmable inputs to drive mechanical and therapeutic outputs, offering a robust platform for bioresponsive soft robotics and in situ drug delivery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsDrug LiberationPolyethylene GlycolsSerum Albumin, BovineDoxorubicinAnimalsCattlePrinting, Three-DimensionalPepstatinsAutonomous Robots

Stichwörter der Autor:innen

autonomous actuatorsbiochemical logicendogenous biochemical cueshydrogelsprotein‐driven materials

Substanzen

HydrogelsPolyethylene GlycolsSerum Albumin, Bovinepoly(ethylene glycol)diacrylateDoxorubicinPepstatinspepstatin

Autor:innen und Institutionen

  • Department of Materials Science and Engineering, Technion Israel Institute of Technology, Haifa, Israel.

ORCID-Profile: Alejandro Sosnik, Luai R Khoury

Förderung

  • Israeli Centers for Research Excellence
  • Neubauer Family Foundation
  • Tamara and Harry Handelsman Academic Chair

Zitieren

APA

Liu, Y., Potthuri, H., Sosnik, A., & Khoury, L. R. (2026). Autonomous Hydrogel Actuators Programmed by Endogenous Biochemical Logic for Dual‐Stage Morphing and Drug Release. Advanced Materials, 38(12). https://doi.org/10.1002/adma.202516809

Vancouver

Liu Y, Potthuri H, Sosnik A, Khoury LR. Autonomous Hydrogel Actuators Programmed by Endogenous Biochemical Logic for Dual‐Stage Morphing and Drug Release. Advanced Materials. 2026;38(12). doi:10.1002/adma.202516809

BibTeX
@article{Liu2026,
  author = {Liu, Yuchen and Potthuri, Harischandra and Sosnik, Alejandro and Khoury, Luai R},
  title = {Autonomous Hydrogel Actuators Programmed by Endogenous Biochemical Logic for Dual‐Stage Morphing and Drug Release},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {12},
  doi = {10.1002/adma.202516809}
}
Kostenlos starten →